Please search for your last name

The University of Texas MD Anderson Cancer Center
Rheumatology & Clinical Immunology
Dr. Abdel-Wahab is a rheumatologist and immuno-epidemiologist serves as an Assistant Professor in the Section of Rheumatology and Clinical Immunology and holds a joint faculty appointment as an Assistant Professor in the Department of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center. She also serves as an Associate Professor and Consultant of Rheumatology at Assiut University Hospitals, Faculty of Medicine, Assiut University in Egypt. Dr. Abdel-Wahab research focuses on the rheumatic and autoimmune syndromes arising in the context of cancer and its therapy. She is the recipient of a K01 Mentored Research Scientist Development Award from the National Institute of Allergy and Infectious Diseases (NIAID) to primarily investigate the association of specific immune cell signatures and inflammatory cytokines with the occurrence of inflammatory and immune-related adverse events in cancer patients receiving immunotherapy and evaluate the full impact of these therapies including its potential toxicity and symptom burden on the patients’ quality of life.
no photo
University hospital Habib Bourguiba of Sfax
Autoimmunity, Cancer, and immunogenetics resarch laboratory, LR18SP12
Tel Aviv Sourasky Medical Center
Internal Medicine H
no photo
ATILIM UNIVERSITY
Medical Biology
no photo
BUHLMANN Laboratories
Development
InterK Peptide Therapeutics Ltd
Building 3
Michael Agrez, MBBS, MS, PhD, FRCS, FRACS, is Chief Executive Officer and Chief Scientific Officer of InterK Peptide Therapeutics Limited based in Sydney, Australia. Michael’s career background is a combination of cancer-related cell biology and clinical practice as a colorectal surgeon since working at the Mayo Clinic in 1980. During his 30-year tenure with The University of Newcastle, Australia, he has published numerous articles in international peer-reviewed journals that cover aspects of epidemiology, cancer screening, molecular biology, biochemistry and more recently immunology. During the past 7 years InterK has developed immuno-modulating peptides that have potential to inhibit autoimmune responses, suppress cancer growth, enhance vaccination efficacy, repair ultraviolet radiation-induced DNA damage responsible for skin cancer and stimulate immunity in the elderly.
no photo
Dow University of Health Sciences
Neurology
no photo
LABORATORIO GERMANO DE SOUSA
Autoimmunity
no photo
King Faisal specialized Hospital and Research Center
Pediatric Allergy and Immunology
Université Paris Cité
Rhumatologie
Yannick Allanore is Professor of Rheumatology at the Paris Descartes University in Paris since 2008. Professor ALLANORE is the Head of a research group working on the cardio-pulmonary aspects of systemic sclerosis and other chronic inflammatory rheumatic diseases through clinical research programs and basic research ones, including genetic and cellular biology approaches, and also an animal model platform covering various models of inflammatory driven fibrosis (INSERM U1016, Cochin Institute). He is vice-director of Cochin Institute. He has published over 450 papers in peer-review journals, H-Index 70. Professor Allanore is a member of several professional bodies, including the French Rheumatology Society and the American College of Rheumatology. He is the former elected chairman (2013-2019) of the The EUROPEAN Scleroderma Trials and Research group (EUSTAR). He is member of the Steering Committee of the World Scleroderma FOUNDATION, he was the chairman of the programme of the 2020 world scleroderma congress.
no photo
Canadian Blood Services
Centre for Innovation
no photo
Istanbul Medipol University
International school of medicine
no photo
Istanbul Medipol University
International School of Medicine
no photo
Werfen - Autoimmunity
Research and Development
LMU Munich
Department of Medicine IV
Hans-Joachim Anders received his clinical training at the University of Munich and became a board-certified internist, nephrologist, rheumatologist, and immunologist. He directs the Division of Nephrology at the Inner City Campus of the University of Munich. As a professor of nephrology at the University of Munich, he teaches all aspects of clinical nephrology and coordinates the Medical Faculty`s “Molecular Medicine” research program for medical students. His own international research lab focusses on the molecular mechanisms of kidney injury, inflammation, and repair with a special interest in translational aspects and preclinical drug testing. He has published more than 400 original articles, reviews, and book chapters and received several national and international awards, e.g., the award for outstanding contributions in basic science in nephrology of the European Renal Association in 2018. He serves the ERA and the ISN in various boards devoted to clinical nephrology and translational research and is Editor-in-Chief elect of Nephrol Dial Transplantation.
University of Brescia / ASST Spedali Civili di Brescia
Dept Clinical & Experimental Sciences / Unit of Rheumatology & Clinical Immunology
Laura Andreoli specialized in Rheumatology in 2010 and got her PhD degree in “Methodology of Clinical Research” in 2015 at the University of Brescia (Italy). She’s been working as Assistant Professor (2014-2019) and Associate Professor of Rheumatology (2019-ongoing) at the University of Brescia and as Consultant Physician at the Rheumatology and Clinical Immunology Unit of Spedali Civili in Brescia, where a Lupus Clinic has been active since 2013. Her main interests include the pathogenesis, diagnosis and treatment of systemic autoimmune diseases, particularly systemic lupus erythematosus and the antiphospholipid syndrome. The research activity has been conducted within the frame of national/international networks. Since 2006 she’s been working in the Pregnancy Clinic in Brescia (joined team of rheumatologists, gynecologists, neonatologists), which is dedicated to the management of pregnancy in patients with inflammatory arthritis and systemic autoimmune diseases, and to the study of predictors of outcome and implications of the use of anti-rheumatic drugs (conventional and biologic) in pregnant patients. In 2018 the Italian Society for Rheumatology launched the “Italian Registry of Pregnancy in Rheumatic Diseases” (P-RHEUM.it Study). Dr. Andreoli is co-PI of the project together with Prof. Tincani. She is author/coauthor of nearly 180 publications on international journals indexed by PubMed.
no photo
Cape Coast Teaching Hospital
Diabetes Management Nurse
no photo
Allergologia ed Immunologia Clinica
Dipartimento di Scienze Mediche
no photo
University Clinical Centre of Serbia
Clinic for Allergy and Immunology